Keyphrases
Mouse Model
100%
MicroRNA
100%
Parkinson's Disease
100%
Parkinson's Disease Model
100%
Substantia Nigra Pars Compacta
50%
Dopamine
25%
Differentially Expressed
25%
Clinical Model
25%
Early Diagnosis
12%
Next-generation Sequencing
12%
Neurotransmitters
12%
Serum Levels
12%
Neurodegenerative Diseases
12%
Potential Biomarkers
12%
Histological Analysis
12%
Induced Loss
12%
Dopamine Transporter
12%
Tyrosine Hydroxylase
12%
Hydrochloride
12%
Caudate-putamen
12%
MiR-133b
12%
Dopaminergic Neurodegeneration
12%
Motor Symptoms
12%
MiR-124
12%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
microRNA
100%
Parkinson's Disease
100%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
54%
Mitochondrial Permeability Transition Pore
45%
Biological Marker
27%
Disease
18%
Dopamine Receptor Stimulating Agent
18%
Nerve Degeneration
9%
Neurotransmitter
9%
Degenerative Disease
9%
Dopamine Transporter
9%
Tyrosine 3 Monooxygenase
9%
Neuroscience
Parkinson's Disease
100%
MicroRNA
100%
Mitochondrial Permeability Transition Pore
55%
Substantia Nigra Pars Compacta
44%
Dopaminergic
22%
Diagnosis of Parkinson's Disease
22%
Neurodegeneration
11%
Neurotransmitter
11%
Neurodegenerative Disorder
11%
Dopamine Transporter
11%
Tyrosine Hydroxylase
11%
Chloride
11%
Putamen
11%
Tetrahydropyridine
11%
Immunology and Microbiology
Mouse Model
100%
Substantia Nigra Pars Compacta
100%
Metabolite
25%
Next Generation Sequencing
25%
Blood Level
25%
Putamen
25%